Elelyso®

ELELYSO® (taliglucerase alfa) for injection is a plant-based treatment option indicated for the treatment of patients 4 years of age and older with a confirmed diagnosis of Type 1 Gaucher disease.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

Elelyso® Referral Form

WHAT IT TREATS:
MANUFACTURER:

Pfizer Inc.

CLASS:
Enzyme Replacement Therapy
PRESCRIBED BY:

Hematologists, Oncologists, or Liver, Genetic or Orthopedic Specialists

 

 

HOW ADMINISTERED:
Intravenous Infusion
FREQUENCY:

Every other week

Length of infusion:
60-120 mins